Fresh analysis reveals that patients who stop using blockbuster GLP-1 drugs like Mounjaro or Wegovy can put back on reduced body mass much more quickly than those who stop conventional diet and exercise plans.
Findings released in a major health publication demonstrates that while overweight people can lose a large proportion of their total mass while undergoing treatment, the mass comes back at an average rate of nearly a kilo each month once they quit.
"People purchasing such drugs must be cognizant of the risk of rapid weight regain when the treatment ends," stated expert Dr. Susan Jebb.
This pace of recovery means a return to starting mass in about one and a half years.
Analyzing Therapies
The analysis, which examined dozens of studies involving thousands of patients, contrasted the outcomes of GLP-1 agonists with conventional dieting.
Researchers emphasize that people who shed pounds through lifestyle changes alone usually experience a slower weight regain—around 100 grams monthly—after stopping.
Understanding the Fast Rebound
Experts believe the way of the drugs accounts for the heightened regain.
GLP-1 drugs copy a body's own chemical called GLP-1, which moderates hunger.
"Sustained high doses of GLP-1 levels several times higher than normal may cause the body to generate a reduced amount of its own natural hormone, and may also diminish responsiveness to its actions," said Dr. Adam Collins, a nutrition expert.
"Discontinuation of this medication means hunger is uncontrolled, making excessive eating much more probable."
A Chronic Condition?
Medical guidelines advise the injections for individuals with obesity-related health risks, accompanied by prescribed diet and exercise modifications.
Professionals contend that, due to the high risk of weight regain, the therapy might need to be long-term.
This view is echoed by pharmaceutical companies, who note that the findings "emphasize the long-term character of excess weight," similar to managing conditions like high blood pressure.
User Experiences
Individuals who have come off the medication describe a powerful return of appetite.
"I experienced something activating and I was suddenly starving," said an individual.
This difficulty is exacerbated if patients have not adopted sustainable lifestyle or habit modifications during therapy.
Widespread Adoption
Recent estimates suggest that a significant number of people in the UK have used these injections in the last 12 months, with desire remaining high.
- Adoption is greater among women than males.
- The middle-aged age group shows the greatest usage rates.
- Many access the medications through private prescriptions rather than the NHS.
In conclusion, researchers caution that while these medications are potent agents for shedding pounds, they are not a permanent fix and lasting health benefits hinges on combined behavioural changes.
